National Access Director, Payer Strategy for Tab-Cel Remote

Pierre Fabre Pharmaceuticals (USA); Los Angeles (CA); À distance; USD 200 000 - 270 000; Plein temps

Avantages offerts par ce poste

Bonus program

Healthcare benefits

401(k) plan

PTO & holidays

Parental leave

Résumé du poste

Pierre Fabre Pharmaceuticals (USA) is preparing for the launch of Tab-Cel, an allogeneic T-cell immunotherapy, with a focus on securing payer coverage and rapid access post-approval. The National Access Director will lead payer engagement, pre/post-approval information exchange, and coordination with field teams to ensure timely reimbursement readiness across national and regional payers.

The role emphasizes collaboration with Cardiology?

Qualifications

• Strong, pre-existing working experience with national and regional payers.
• Deep knowledge of inpatient and outpatient reimbursement dynamics and hospital access economics.
• 10+ years of biotech/pharma experience with direct coverage and reimbursement dynamics of complex therapies.

Responsabilités

• Operate in compliance with laws, regulations and policies governing Pierre Fabre activities.
• Educate payer segments and treatment center stakeholders on the value proposition of Tab‑Cel to enable urgent access post-approval.
• Support national and regional payer engagement to facilitate pre- and post-approval coverage.
• Collaborate with field medical directors and accounts teams to prepare sites for reimbursement and prior authorization processes.

Connaissances

Payer relations

Healthcare policy

Cross-functional collaboration

Strategic communication

Description du poste

Pierre Fabre Pharmaceuticals (USA) is preparing for the launch of Tab-Cel, an allogeneic T-cell immunotherapy, with a focus on securing payer coverage and rapid access post-approval. The National Access Director will lead payer engagement, pre/post-approval information exchange, and coordination with field teams to ensure timely reimbursement readiness across national and regional payers.

The role emphasizes collaboration with Cardiology?